GSPT1 Targeted Protein Degradation: Molecular Glue Design and Development Strategies

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Consult with Our Experts

What Is GSPT1 (eRF3a), and Which Forms Are Suitable for Degrader Development?

GSPT1, also known as eukaryotic release factor 3a (eRF3a), is a GTP-binding protein encoded by the GSPT1 gene. It functions as an essential translation termination factor by interacting with eukaryotic release factor 1 (eRF1) and participating in the release of newly synthesized polypeptides from ribosomes. During translation termination, GSPT1 forms a complex with eRF1 and GTP. Following recognition of a stop codon, GSPT1 hydrolyzes GTP, facilitating conformational changes in the termination complex and subsequent peptide release. Beyond its role in translation, GSPT1 also interacts with poly(A)-binding protein (PABP), connecting translation termination with mRNA regulation and stability.

Human GSPT1 contains approximately 637 amino acids and can be divided into three major structural regions: an N-terminal domain, a middle region, and a C-terminal functional domain. The N-terminal region contains a PABP-interacting motif, whereas the conserved C-terminal region contains the GTPase machinery and domains responsible for interactions with eRF1. Importantly, the C-terminal domain 3 also contains a β-hairpin structural degron that enables GSPT1 recognition by cereblon (CRBN) in the presence of molecular glue degraders. This degron, particularly Gly575 (G575), is the most established structural hotspot for GSPT1 degradation.

Two closely related eRF3 proteins, GSPT1 (eRF3a) and GSPT2 (eRF3b), participate in translation termination. Their structural similarity is relevant to degrader selectivity because some CRBN modulators can induce the degradation of both proteins. GSPT1 transcript variants and experimentally introduced degron mutations should also be considered when defining the intended target population. In particular, G575N and other β-hairpin alterations can impair molecular glue-mediated recruitment. These mutations are useful mechanistic resistance models rather than established mutation-specific GSPT1 degrader targets.

Table 1. GSPT1 Structural Regions and Their Implications for Degrader Development.

From a drug design perspective, GSPT1 differs from conventional kinase or receptor targets. Although it contains a GTP-binding domain, its established degradation mechanism does not depend on occupying the nucleotide-binding pocket. Instead, CRBN molecular glues exploit a surface degron that was not originally recognized as a conventional small-molecule binding pocket. This distinction determines why molecular glue optimization currently has a stronger experimental foundation than conventional GSPT1-directed PROTAC development.

Which GSPT1 Degraders Have Been Developed?

GSPT1 degradation research has developed from the discovery of CC-885 into several generations of CRBN-dependent molecular glues, non-IMiD CRBN modulators, and hybrid degraders combining molecular glue and PROTAC mechanisms. Early studies established the GSPT1 β-hairpin degron as a structurally accessible recruitment element, while subsequent optimization focused on improving degradation selectivity, modifying CRBN-binding chemotypes, and expanding the range of proteins that can be degraded within a single molecular architecture.

Table 2. Representative Developed GSPT1 Degraders and Their Molecular Design Features.

These studies highlight several important design principles. First, the GSPT1 β-hairpin degron can be exploited by structurally different CRBN modulators, meaning that the glutarimide-containing IMiD scaffold is not the only possible starting point. Second, modification of the molecular region extending beyond the CRBN-binding core can substantially change GSPT1 recognition and neosubstrate selectivity. Third, heterobifunctional molecules can induce GSPT1 degradation even when their nominal target-binding moiety recognizes another protein. In these cases, GSPT1 degradation is driven by the CRBN-binding component acting as a molecular glue, rather than by direct binding of the other target ligand to GSPT1.

Therefore, the most established GSPT1 development strategy remains structure-guided molecular glue optimization. Hybrid PROTAC approaches provide additional opportunities, but their mechanisms must be separated experimentally to establish whether GSPT1 is recruited directly by the glue component or through a distinct target-binding interaction.

Designing CRBN-Dependent Monovalent Molecular Glues for GSPT1

CRBN-dependent monovalent molecular glues represent the most extensively characterized approach to GSPT1 degradation. Unlike conventional PROTACs, these compounds do not contain two independent protein-binding ligands connected by a conventional linker. Instead, one small molecule binds CRBN and creates a new protein-protein interaction surface that accommodates the GSPT1 β-hairpin degron. The resulting CRBN-GSPT1 complex promotes ubiquitination and proteasomal degradation.

Recruitment Site: The GSPT1 β-Hairpin Degron (Residues 569–578) and the G575 Geometry Rule

The most important structural element for CRBN-dependent GSPT1 degradation is the β-hairpin loop located near the C-terminal region of GSPT1 domain 3. The experimentally characterized degron spans approximately residues 568–576, although residue boundaries may vary slightly with the construct or structural description. This loop presents a compact recognition surface that fits against the molecular glue-bound CRBN protein. Rather than recognizing a deep hydrophobic cavity, the degrader exploits a combination of backbone hydrogen bonds, van der Waals contacts, and local steric complementarity.

Three residues are particularly important for understanding this recognition mechanism:

• Lys572 (K572): Its backbone carbonyl contributes to the hydrogen-bond network with CRBN and helps stabilize the degron orientation.
• Lys573 (K573) and Ser574 (S574): Their backbone carbonyl groups participate in additional hydrogen-bond interactions with CRBN residues, helping maintain the β-hairpin recognition geometry.
• Gly575 (G575): This glycine provides the small side-chain geometry needed for close molecular packing. Its position is particularly important for accommodating the molecular glue and maintaining the ternary interface.

The G575 position is especially important because replacing glycine with a larger residue can introduce steric interference and disrupt the productive CRBN-GSPT1 interface. G575N has been reported to abolish degradation induced by CC-885 and CC-90009, while G575A produces a partial reduction in degradation in a reported experimental system. Deletions involving the surrounding β-hairpin residues can also interfere with degrader recognition. These observations establish G575 as a key structural determinant rather than simply a sequence marker.

For molecular glue development, structural modeling should therefore prioritize the complete β-hairpin conformation rather than evaluating G575 as an isolated residue. The orientation of the peptide backbone, hydrogen-bond donor and acceptor positions, and the available space surrounding G575 should be considered together. Docking against a single static GSPT1 structure may not fully capture these factors, so molecular dynamics and experimental ternary-complex validation are valuable for distinguishing favorable binding poses.

Warhead Selection: Glutarimide-Containing IMiD and Non-IMiD Chemotypes for GSPT1 Recruitment

In CRBN-dependent molecular glues, the term warhead refers to the small-molecule scaffold that binds CRBN and establishes the additional recognition surface required for GSPT1 recruitment. The compound does not need to contain an independently validated GSPT1-binding pharmacophore. Instead, the non-CRBN-binding portion of the molecular glue helps create the interaction interface between CRBN and the GSPT1 degron.

CC-885 provides the principal structural precedent for this approach. Its molecular architecture contains three functionally important regions:

• Glutarimide ring: Anchors the molecule within the CRBN tri-tryptophan binding pocket through the characteristic recognition pattern of IMiD-derived CRBN ligands.
• Isoindolinone core: Extends above the CRBN surface and approaches the GSPT1 β-hairpin, allowing the molecular glue to contribute directly to the induced protein-protein interface.
• Urea and chlorophenyl extension: Provides additional hydrogen-bonding and hydrophobic interactions that help stabilize the CRBN-GSPT1 complex.

CC-90009 demonstrates how this architecture can be optimized. It retains the glutarimide and isoindolinone framework but modifies the extended substituent region. Its difluoroacetamide-containing extension forms an interaction with CRBN His353, while the chlorophenyl group is positioned near the β-sheet core of GSPT1 domain 3. This arrangement preserves productive GSPT1 recruitment while changing the local interaction network relative to CC-885. The comparison illustrates why modifying peripheral substituents can be more informative than simply increasing the affinity of the CRBN-binding group.

Non-IMiD structures provide another direction. KMG-1068 demonstrates that a compound without the characteristic glutarimide group can still bind the IMiD-binding region of CRBN and induce GSPT1/GSPT2 degradation. SJ6986 and SJ7023 further demonstrate the potential of sulfonamide-containing CRBN modulators. These compounds provide evidence that different chemical scaffolds can be explored while preserving the ability to induce CRBN-dependent substrate recruitment.

For new scaffold development, the recommended approach is to compare several chemotypes rather than relying exclusively on one IMiD structure. The selection process should evaluate CRBN binding, GSPT1 recruitment, ternary-complex cooperativity, degradation depth, and neosubstrate selectivity independently. A compound with strong CRBN affinity but insufficient interaction with the GSPT1 degron may not produce effective degradation.

Linker Design: Exit Vectors and Spacer Chemistry in the Isoindolinone-Urea/Carbamate Region

A conventional PROTAC linker connects two independently binding ligands. Monovalent molecular glues do not use this architecture. Therefore, the linker-related design problem in GSPT1 molecular glues is better understood as the optimization of internal spacer regions and substituent orientations within the small-molecule scaffold. These structural elements determine how the CRBN-binding core presents additional chemical groups toward the GSPT1 β-hairpin and surrounding protein surface.

The CC-885 and CC-90009 structures demonstrate that the region extending from the isoindolinone core is particularly important. The urea-containing extension of CC-885 contributes to hydrogen bonding with CRBN, while the associated aromatic substituent provides additional contacts near GSPT1. CC-90009 modifies this region with a difluoroacetamide-containing arrangement, changing the local hydrogen-bonding pattern and the orientation of the terminal aromatic group. These differences show that the extended molecular region participates in both CRBN recognition and neosubstrate selectivity.

The following structural factors should be evaluated during optimization:

• Attachment position: Preserve the CRBN-binding orientation while modifying solvent-exposed substituents that can project toward the GSPT1 β-hairpin.
• Spacer length: Compare short and extended substituents to determine whether the additional group can reach the GSPT1 interaction surface without introducing steric interference.
• Hydrogen-bonding geometry: Evaluate urea, carbamate, amide, and related functional groups for their ability to establish complementary donor-acceptor interactions.
• Aromatic substituents: Explore halogenated and other substituted aromatic groups to adjust hydrophobic contacts and local steric complementarity.
• Molecular flexibility: Balance conformational adaptability with sufficient preorganization to reduce the entropic penalty of ternary-complex formation.

A useful development strategy is to construct matched analog series in which the CRBN-binding core remains constant while the substituent region is systematically modified. This makes it easier to determine whether changes in GSPT1 degradation result from improved CRBN engagement, stronger degron recognition, or altered ternary-complex geometry.

E3 Ligase Selection: Cereblon Tri-Trp Pocket Engagement and CRBN-Dependent Validation

CRBN is the established E3 ligase substrate receptor for the best-characterized GSPT1 molecular glues. It functions as part of the CRL4^CRBN ubiquitin ligase complex, in which DDB1 connects CRBN to the CUL4-based ligase machinery. The molecular glue occupies the CRBN-binding pocket and changes its substrate recognition properties, allowing the GSPT1 β-hairpin to associate with the CRBN surface.

For glutarimide-containing compounds, the tri-tryptophan pocket is the primary anchoring region. The glutarimide ring establishes the core CRBN interaction, while the remaining scaffold extends toward the GSPT1 recognition surface. This arrangement means that CRBN binding and GSPT1 recruitment must be evaluated as related but distinct molecular events.

• CRBN binding: Confirm that the selected scaffold engages the CRBN pocket and retains binding after structural modification.
• GSPT1 recruitment: Measure CRBN-GSPT1 complex formation and determine whether the interaction depends on the G575-containing degron.
• Ligase dependence: Use CRBN depletion or knockout, competitive CRBN ligands, and appropriate ubiquitination-pathway controls to verify the intended mechanism.
• Proteasomal degradation: Distinguish actual GSPT1 protein degradation from reduced expression or other indirect changes in protein abundance.

Importantly, a CRBN ligand should not be selected only because it binds strongly to the tri-tryptophan pocket. The preferred structure is the one that supports productive CRBN-GSPT1 recognition, sufficient ubiquitination, and the desired degradation selectivity.

Table 3. Structure-Guided Design Recommendations for CRBN-Dependent GSPT1 Molecular Glues.

Designing Next-Generation GSPT1 Degraders: Covalent, Bivalent, and Non-CRBN Routes

Although CRBN-dependent molecular glues provide the strongest experimental foundation for GSPT1 degradation, their dependence on a particular substrate-recognition surface creates opportunities for alternative approaches. Future research may investigate additional GSPT1 degrons, covalent or reversible-covalent molecular glue architectures, bivalent interaction strategies, and recruitment through alternative E3 ligase substrate receptors. These directions remain exploratory and should not be confused with established GSPT1 degradation mechanisms.

Recruitment Site: Beyond the Canonical G-Loop and Alternative Surface Degrons

Most established GSPT1 molecular glues rely on the C-terminal β-hairpin degron. This region provides the structural recognition element required for CRBN recruitment, but it also creates a potential limitation: changes to the loop conformation or key residues can reduce degrader activity. G575N, for example, disrupts the recognition geometry and provides a useful model for studying degrader resistance.

An alternative development direction is to identify other accessible GSPT1 surfaces that can support induced protein-protein interactions. The GTPase domain, domain 2/3 interface, and regions involved in eRF1 or PABP interactions may provide starting points for structural screening. However, no alternative GSPT1 surface has yet been established as a broadly validated replacement for the canonical G-loop in CRBN-mediated molecular glue degradation.

A practical discovery strategy should combine structural modeling with experimental mapping. Candidate surface regions can be evaluated through fragment screening, mutational analysis, protein interaction studies, and molecular dynamics. Mutations that selectively disrupt degrader recruitment without globally destabilizing GSPT1 are especially informative because they can help distinguish direct degron recognition from nonspecific protein destabilization.

Warhead Selection: Covalent and Reversible-Covalent Glue Chemotypes

Covalent molecular glues represent a potential route for stabilizing protein-protein interactions through irreversible or reversible chemical engagement. In principle, a suitably positioned reactive group could improve the residence time of a GSPT1-recognition complex or introduce an additional interaction with an E3 ligase surface. However, covalent or reversible-covalent GSPT1 molecular glues have not been established by the representative GSPT1 degradation studies discussed in this article.

Any future covalent design would require a clearly defined binding orientation and an accessible nucleophilic residue positioned near the proposed reactive group. Gly575 itself is not a conventional nucleophilic covalent-attachment site; its established function is to provide the small side-chain geometry required for the β-hairpin recognition interface. Therefore, covalent chemistry should not be introduced at this position simply because it is a critical degron residue.

• Reversible-covalent design: Explore only when a suitable target residue and reversible reaction mechanism can be structurally justified.
• Noncovalent reference: Retain CC-885-, CC-90009-, and KMG-1068-related interaction models as benchmarks for evaluating whether a new chemotype improves substrate recruitment.
• Selectivity assessment: Compare covalent engagement across GSPT1, GSPT2, and other proteins containing accessible nucleophilic residues.
• Mechanism confirmation: Distinguish covalent target engagement from actual E3-dependent ubiquitination and proteasomal degradation.

Linker Design: Linker-Containing Glues, Intramolecular Bivalent Glues, and Dual-Degrader Architectures

Conventional molecular glues are generally monovalent and do not require an external linker. However, adding an appropriately positioned second recognition element may provide an opportunity to stabilize additional contacts within the CRBN-GSPT1 interface. Such a bivalent molecular glue architecture could potentially improve ternary-complex cooperativity or compensate for weak interactions at one region of the interface.

A structure-guided approach would begin by identifying solvent-exposed positions on the molecular glue scaffold that can tolerate extension without disrupting CRBN binding. The extension could then be designed to interact with a second region of GSPT1 or an adjacent CRBN surface. Short linkers, rigid heterocycles, and conformationally constrained spacers could be compared to determine whether additional contacts improve complex stability.

Dual-degrader architectures provide a more experimentally supported development direction. GBD-9 combines BTK degradation through a PROTAC mechanism with GSPT1 degradation through a CRBN molecular glue mechanism. BWA-6047 and DP-15 provide additional examples of compounds designed to degrade two or more proteins through combined PROTAC and molecular glue characteristics. These examples demonstrate the potential of combining multiple degradation mechanisms, although they do not establish a universal GSPT1-specific linker architecture.

• Linker-containing molecular glues: Explore scaffold extensions that introduce additional contacts while retaining the monovalent CRBN-binding mechanism.
• Intramolecular bivalent structures: Investigate whether two complementary interaction groups can stabilize different regions of the same GSPT1-CRBN interface.
• Dual-degrader architectures: Combine a target-specific ligand with a CRBN-binding component that independently supports GSPT1 recruitment.
• Linker optimization: Evaluate molecular size, conformational freedom, and ternary-complex orientation rather than relying exclusively on increased linker length.

E3 Ligase Selection: Non-CRBN CRL Substrate Receptors and Ligase-Matched Design

The discovery of alternative E3 ligase recruitment mechanisms could help overcome the limitations of relying exclusively on CRBN. However, GSPT1 degradation through an alternative CRL substrate receptor has not yet been established with the same structural and mechanistic depth as CRBN-dependent degradation.

A useful research strategy is to screen molecular glue libraries against GSPT1 while comparing wild-type cells with CRBN-deficient systems. Hits that retain GSPT1 degradation in the absence of CRBN can then be investigated through proteomic target deconvolution, proximity assays, and systematic perturbation of candidate E3 ligase components. A preliminary 2026 research abstract reported the identification of both CRBN-dependent and CRBN-independent screening hits, although the alternative ligase identities and detailed molecular structures were not disclosed. These findings support continued exploration but do not yet establish a specific non-CRBN GSPT1 degrader mechanism.

• CRBN-independent screening: Use CRBN-deficient systems to distinguish alternative recruitment mechanisms from residual CRBN activity.
• Candidate E3 identification: Combine proteomic analysis, proximity labeling, and genetic perturbation to identify the responsible substrate receptor.
• Ligase compatibility: Confirm that the candidate receptor can support GSPT1 recruitment, ubiquitination, and degradation.
• Structure-guided optimization: Optimize the molecular glue scaffold only after the relevant ligase-substrate interaction has been experimentally established.

Table 4. Emerging GSPT1 Degrader Strategies and Their Research Status.

Common Failure Causes and Optimization Strategies for GSPT1 Degraders

GSPT1 degrader development involves more than identifying a compound that binds CRBN or produces a reduction in total GSPT1 abundance. Successful degradation requires the correct degron geometry, productive ternary-complex formation, adequate cellular exposure, and sufficient selectivity across related proteins and other CRBN neosubstrates. The following challenges provide a practical framework for troubleshooting unsuccessful molecular glue and hybrid degrader designs.

Weak G-Loop Recognition and Unproductive CRBN-GSPT1 Ternary Complex Formation

One of the most important causes of weak GSPT1 degradation is an unfavorable interaction between the molecular glue-bound CRBN surface and the GSPT1 β-hairpin degron. A compound may retain strong CRBN binding but fail to position the GSPT1 loop correctly. Small changes around G575 can disrupt steric complementarity, while alterations to K572, K573, and S574 can weaken the hydrogen-bond network that stabilizes the complex.

Optimization directions:

• Degron geometry: Compare wild-type GSPT1 with G575A, G575N, and other relevant degron variants to determine whether the intended recognition mechanism is preserved.
• Interface modeling: Evaluate hydrogen-bond distances, local steric clashes, and hydrophobic contacts around the β-hairpin rather than relying only on binary CRBN affinity.
• Scaffold optimization: Modify the isoindolinone-linked substituent region to improve GSPT1-facing interactions while retaining CRBN engagement.
• Ternary-complex evaluation: Use appropriate binding and proximity assays to distinguish weak recruitment from nonproductive complex formation.

Off-Target Neosubstrate Degradation and Insufficient Molecular Selectivity

CRBN molecular glues can recruit more than one protein because different neosubstrates may share compatible structural features. CC-885 demonstrates this limitation: although it induces potent GSPT1 degradation, it also affects other CRBN neosubstrates, including IKZF1, IKZF3, and CK1α. CC-90009 demonstrates that structural optimization can improve the preference for GSPT1, while KMG-1068 highlights another selectivity consideration because it induces degradation of both GSPT1 and GSPT2.

Optimization directions:

• Structure-based selectivity: Modify peripheral substituents that contribute to the induced CRBN-substrate interface rather than focusing exclusively on CRBN affinity.
• Neosubstrate profiling: Use quantitative proteomics to identify unintended protein depletion across a broad protein panel.
• GSPT1/GSPT2 discrimination: Compare degron sequences and local structural differences to determine whether selective recruitment is feasible.
• Matched analog studies: Relate structural changes to both desired GSPT1 degradation and unwanted neosubstrate depletion.

Poor Cellular Exposure, Solubility, and Metabolic Stability

Even when a molecular glue forms a productive CRBN-GSPT1 complex in a biochemical assay, its cellular degradation activity may be limited by insufficient intracellular exposure. Molecular weight, hydrogen-bonding capacity, polar surface area, lipophilicity, and metabolic stability can all influence the amount of active compound available to engage the target. These properties become particularly important when the molecular scaffold contains several aromatic substituents or extended polar functional groups.

Optimization directions:

• Solubility: Adjust substituent polarity and functional group distribution without disrupting the CRBN-binding core.
• Permeability: Compare cellular uptake and intracellular exposure across matched analogs with different hydrogen-bonding and polar surface area profiles.
• Metabolic stability: Identify susceptible chemical regions and evaluate appropriate structural modifications.
• Property balance: Compare physicochemical properties alongside CRBN affinity and GSPT1 degradation rather than optimizing one parameter independently.

Biological Context Mismatch: CRBN Availability, GSPT1 Dependency, and GSPT2 Compensation

GSPT1 degradation is influenced by the biological environment in which the degrader operates. CRBN abundance, CUL4 complex activity, proteasomal function, and GSPT1 expression can all affect the observed degradation response. In addition, GSPT2 expression may influence the biological consequences of GSPT1 depletion because both proteins participate in translation termination. GSPT1 degradation can also activate the integrated stress response (ISR), involving GCN1, GCN2, eIF2α, and ATF4. Depending on the biological context, this response may contribute to cell death or adaptive stress signaling.

Optimization directions:

• CRBN availability: Measure CRBN abundance and verify the functionality of the associated ubiquitin ligase machinery.
• Target dependency: Compare GSPT1 expression and degradation response across relevant biological models.
• Paralog assessment: Evaluate GSPT2 expression and determine whether its degradation or compensatory activity changes the experimental outcome.
• ISR characterization: Monitor eIF2α phosphorylation and ATF4-associated responses to distinguish the direct consequences of GSPT1 degradation from secondary adaptive effects.

BOC Sciences Support for GSPT1 Degrader Development

Table 5. BOC Sciences Products and Building Blocks for GSPT1 Degrader Development.

The listed materials are CRBN ligand and conjugation building blocks rather than prevalidated GSPT1-selective molecular glues. Their suitability should be determined through structure-guided design, custom synthesis, and experimental degradation evaluation. BOC Sciences also provides additional in-stock PROTAC raw materials and customized research support for different degrader architectures.

Explore featured products that can expand your research options and accelerate your next discovery.

Access end-to-end service solutions that help bring efficiency, flexibility, and expertise to your research pipeline.

News

• Discovery of Molecular Glue Degraders
• The Next Frontier of PROTACs: Development of Molecular Glues
• Searching for Molecular Glue in Targeted Disease Control

Technical Information

• CRBN vs VHL: Choosing the Right E3 Ligase Ligand for Your PROTAC Project
• Overcoming Off-Target Effects: Reducing Zinc Finger Protein Degradation in CRBN-Based PROTACs
• Pomalidomide-Based PROTACs: Structure-Activity Insights and Optimization Tips